Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.15 AUD | -3.49% | +5.33% | +118.42% |
Apr. 24 | Clarity Pharmaceuticals Completes AU$10.8 Million Retail Entitlement Offer | MT |
Apr. 04 | Clarity Pharmaceuticals Signs Supply Agreement with NorthStar Medical Radioisotopes | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.34B 890M |
---|---|---|---|---|---|
Net income 2024 * | -37M -24.63M | Net income 2025 * | -48M -31.95M | EV / Sales 2024 * | - |
Net cash position 2024 * | 131M 87.08M | Net cash position 2025 * | 89.22M 59.39M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-34.8
x | P/E ratio 2025 * |
-26.8
x | Employees | 41 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.91% |
1 day | -3.49% | ||
1 week | +5.33% | ||
Current month | +48.21% | ||
1 month | +59.62% | ||
3 months | +54.85% | ||
6 months | +213.21% | ||
Current year | +118.42% |
Managers | Title | Age | Since |
---|---|---|---|
Colin Biggin
CEO | Chief Executive Officer | - | 16-12-31 |
Matthew Harris
FOU | Founder | - | 09-12-31 |
David Green
DFI | Director of Finance/CFO | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Roberts
BRD | Director/Board Member | 70 | - |
Robert Thomas
BRD | Director/Board Member | 79 | 21-08-24 |
Thomas Ramdahl
BRD | Director/Board Member | 68 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 4.15 | -3.49% | 577 539 |
24-05-20 | 4.3 | +3.86% | 899,648 |
24-05-17 | 4.14 | +5.34% | 1,575,053 |
24-05-16 | 3.93 | +2.34% | 861,682 |
24-05-15 | 3.84 | -2.54% | 777,031 |
Delayed Quote Australian S.E., May 20, 2024 at 11:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+118.42% | 860M | |
+9.58% | 115B | |
+12.41% | 106B | |
-2.59% | 21.96B | |
-12.38% | 21.87B | |
-5.29% | 19.21B | |
-3.35% | 18.08B | |
-38.57% | 17.71B | |
+7.51% | 14.32B | |
+35.67% | 12.42B |
- Stock Market
- Equities
- CU6 Stock